期刊文献+

可溶性鸟苷酸环化酶介导NO信号转导的结构基础及其分子机制研究 被引量:8

Structural basis and molecular mechanism of soluble guanylate cyclase in NO-signaling transduction
原文传递
导出
摘要 可溶性鸟苷酸环化酶(sGC)是NO信号转导通路中的核心金属酶,是NO的敏感器和受体.sGC含有?和?两个亚基,每个亚基分别具有3个结构域,包括血红素结构域、中心结构域和催化结构域,两个亚基的血红素结构域共享有一个血红素,NO结合到sGC的血红素后,激活sGC,催化其底物GTP转化为二级信号分子cGMP,开启PKG信号通路,导致血管舒张.NO信号转导通路异常将导致多种疾病的发生,如多种心血管疾病、肺动脉高血压、心力衰竭及神经退行性疾病等.近20年来,关于sGC的结构、功能、激活机制及其在生理与病理中的作用有了很多进展.本文重点对sGC的结构、功能及其活化/失活机制研究进展进行综述. Soluble guanylatecyclase (sGC), as a NO receptor, is a key metalloenzyme in mediating NO-signaling transduction, sGC is activated by NO to catalyze the conversion of guanosine 5'-triphosphate (GTP) to cyclic guanylate monophosphate (cGMP). The dysfunction of NO signaling results in many pathological disorders, including several cardiovascular diseases such as arterial hypertension, pulmonary hypertension, heart failure and so on. Significant advances in its structure, function, mechanism, and physiological & pathological roles have been made throughout the past fifteen years. We herein review the progress of sGC on structural, functional investigations, as well as the proposed activation/deactivationmechanism. The heme-dependent sGC stimulators and heme- independent sGC activators have also been summarized briefly.
出处 《中国科学:化学》 CAS CSCD 北大核心 2014年第4期572-585,共14页 SCIENTIA SINICA Chimica
基金 国家自然基金(91013001 20771029 31270869) 上海市科委浦江人才计划(08PJ14017)资助
关键词 NO NO信号转导 SGC nitric oxide, NO signaling transduction, soluble guanylatecyclase
  • 相关文献

参考文献102

  • 1Denninger JW, Marletta MA. Guanylate cyclase and the NO/cGMP signaling pathway. Biochim Biophys Acta, 1999, 1411: 334-350.
  • 2Evgenov OV, Pacher P, Schmidt PM, Hasko G, Schmidt HH, Stasch JP. NO-independent stimulators and activators of soluble guanylate cyclase: discovery and therapeutic potential. Nat Rev Drug Discov, 2006, 5: 755-768.
  • 3Chen K, Pittman RN, Popel AS. Nitric oxide in the vasculature: where does it come from and where does it go? A quantitative perspective. Antioxid Redox Signal, 2008, 10: 1185-1198.
  • 4Wang-Rosenke Y, Neumayer HH, Peters H. NO signaling through cGMP in renal tissue fibrosis and beyond: key pathway and novel therapeutic target. Curr Med Chem, 2008, 15: 1396-1406.
  • 5Derbyshire ER, Marletta MA. Structure and regulation of soluble guanylate cyclase. Annu Rev Biochem, 2012, 81: 533-559.
  • 6Kosowicz JG, Boon EM. Insights into the distal heme pocket of H-NOX using fluoride as a probe for H-bonding interactions. J Inorg Biochem, 2013, 126: 91-95.
  • 7Pacher P, Beckman JS, Liaudet L. Nitric oxide and peroxynitrite in health and disease. Physiol Rev, 2007, 87: 315-424.
  • 8McLaughlin VV, Archer SL, Badesch DB, Barst RJ, Farber HW, Lindner JR, Mathier MA, McGoon MD, Park MH, Rosenson RS, Rubin LJ, Tapson VF, Varge J. ACCF/AHA 2009 expert consensus document on pulmonary hypertension. J Am Coll Cardiol, 2009, 119: 2250-2294.
  • 9Zhong F, Wang H, Ying T, Huang ZX, Tan X. Efficient expression of human soluble guanylate cyclase in Escherichia coli and its signaling-related interaction with nitric oxide. Amino Acids, 2010, 39: 399-408.
  • 10Haase N, Haase T, Kraehling JR, Behrends S. Direct fusion of subunits of heterodimeric nitric oxide sensitive guanylyl cyclase leads to functional enzymes with preserved biochemical properties: evidence for isoform specific activation by ciguates. Biochem Pharmacol, 2010, 80: 1676-1683.

同被引文献108

引证文献8

二级引证文献22

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部